Technologies Available for Licensing
USE OF LIPOXYGENASE INHIBITORS AND PPAR LIGANDS AS ANTICANCER THERAPEUTIC AND INTERVENTION AGENTS
The present invention provides a method for treating and preventing an epithelial cell-derived cancer in a subject in need thereof, comprising administering to the subject an amount of a 5-lipoxygenase inhibitor and PPAR ligand or derivatives thereof, effective to treat or prevent the epithelial cell-derived cancer. Also encompassed by the invention are inhibitors of enzymes that metabolize arachidonic acid.
More Detail:Visit USPTO.GOV
Inventor(s):MULSHINE, J.; JETT, M.